Brown Shipley& Co Ltd Sells 388 Shares of Colgate-Palmolive (NYSE:CL)

Brown Shipley& Co Ltd decreased its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 39.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 600 shares of the company’s stock after selling 388 shares during the period. Brown Shipley& Co [...]

featured-image

Brown Shipley& Co Ltd decreased its position in shares of Colgate-Palmolive ( NYSE:CL – Free Report ) by 39.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 600 shares of the company’s stock after selling 388 shares during the period.

Brown Shipley& Co Ltd’s holdings in Colgate-Palmolive were worth $58,000 at the end of the most recent quarter. Other large investors have also added to or reduced their stakes in the company. Main Street Research LLC raised its position in shares of Colgate-Palmolive by 1.



5% during the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after buying an additional 100 shares during the last quarter. Advisor OS LLC lifted its stake in Colgate-Palmolive by 4.

5% in the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after purchasing an additional 101 shares in the last quarter. BLB&B Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 2.

5% during the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after purchasing an additional 104 shares during the last quarter. ZWJ Investment Counsel Inc.

grew its position in shares of Colgate-Palmolive by 3.1% during the second quarter. ZWJ Investment Counsel Inc.

now owns 3,591 shares of the company’s stock valued at $349,000 after purchasing an additional 109 shares in the last quarter. Finally, Hexagon Capital Partners LLC increased its holdings in shares of Colgate-Palmolive by 9.5% in the second quarter.

Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after purchasing an additional 110 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 0.6 % NYSE:CL opened at $103.66 on Monday.

The stock has a fifty day simple moving average of $103.25 and a 200-day simple moving average of $96.42.

The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.

90. The company has a market cap of $85.05 billion, a price-to-earnings ratio of 32.

80, a price-to-earnings-growth ratio of 3.62 and a beta of 0.40.

Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $109.30.

Colgate-Palmolive Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.50 per share.

This represents a $2.00 dividend on an annualized basis and a yield of 1.93%.

The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Analyst Upgrades and Downgrades Several research firms have weighed in on CL. Piper Sandler began coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They set an “overweight” rating and a $121.

00 price target for the company. UBS Group upped their price target on shares of Colgate-Palmolive from $119.00 to $122.

00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. TD Cowen lifted their price objective on shares of Colgate-Palmolive from $110.00 to $115.

00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. Jefferies Financial Group cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their target price for the company from $103.00 to $95.

00 in a research report on Wednesday, July 24th. Finally, Sanford C. Bernstein boosted their price objective on Colgate-Palmolive from $100.

00 to $103.00 and gave the stock a “market perform” rating in a research note on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the stock.

Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $104.74. Read Our Latest Report on CL Insider Buying and Selling at Colgate-Palmolive In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction dated Tuesday, August 6th.

The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00.

Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website .

In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $102.94, for a total value of $1,522,894.

36. Following the transaction, the insider now owns 5,146 shares in the company, valued at $529,729.24.

The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website . Also, insider Sally Massey sold 15,850 shares of the stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.

28, for a total transaction of $1,636,988.00. Following the sale, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.

76. The disclosure for this sale can be found here . Insiders sold a total of 43,490 shares of company stock valued at $4,486,063 in the last ninety days.

Corporate insiders own 0.34% of the company’s stock. Colgate-Palmolive Profile ( Free Report ) Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally.

It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. Featured Stories Want to see what other hedge funds are holding CL? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for Colgate-Palmolive ( NYSE:CL – Free Report ). Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter .

.